June 19, 2025
Kane Biotech Provides Further Corporate Update
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates…
Pharmaceuticals, Biotechnology and Life Sciences
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates…
FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused…
Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over…
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholdersSAN MATEO, Calif., June 18, 2025 (GLOBE…
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused…
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2…
– First use of camel hemoglobin as a universal oxygen carrier – Unique properties make it an ideal ingredient for…
– New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay,…
Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have…
Live webcast on Wednesday, June 25th at 12:00 PM ETISELIN, N.J., June 18, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc.…